Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation [NA]
The clinical trial evaluating radiofrequency catheter ablation for chronic atrial fibrillation has completed; the update notes status with n…
-
CLINICAL_TRIALS research · 2015-05-21Clinical Trial Update: PRescriptiOn PattERns Of Oral Anticoagulants
A completed clinical trial evaluating prescribing patterns of oral anticoagulants for atrial fibrillation, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation [Phase 3]
Phase 3 trial update evaluating warfarin (Coumadin) for preventing thromboembolism in atrial fibrillation patients undergoing catheter ablat…
-
FDA approval · 2015-05-19FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Amiodarone Hydrochloride (generic) from Chartwell RX, LLC, confirming the generic product's stat…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation [Phase 2, Phase 3]
Clinical trial update for the WATCHMAN Left Atrial Appendage System in atrial fibrillation reports completed Phase 2 and Phase 3 PROTECT tri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Vitamin C for Prophylaxis of Post-operative Atrial Fibrillation in On-pump Cardiac Surgery Procedures [Phase 3]
Phase 3 trial evaluating whether vitamin C can prevent atrial fibrillation after on-pump cardiac surgery; the study is completed and results…
-
CLINICAL_TRIALS withdrawal · 2015-05-13Clinical Trial Update: Vitamin C and Atrial Fibrillation After Cardiac Surgery [Phase 3]
A Phase 3 trial evaluating vitamin C for preventing atrial fibrillation after cardiac surgery was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation [Phase 4]
Phase 4 trial comparing vernakalant to ibutilide for recent-onset atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia [Phase 4]
Phase 4 clinical trial assessing whether fish oils (omega-3 fatty acids) can prevent atrial mechanical stunning and remodeling due to atrial…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion [Phase 4]
Phase 4 clinical trial update on using fish oil (Omega-3 fatty acids) to reduce recurrence of atrial fibrillation after DC cardioversion. Th…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Atrial Fibrillation/Flutter Outcome Risk Determination
This clinical trial update reports outcomes from a Vanderbilt University study focused on determining risk in atrial fibrillation and atrial…
-
FDA approval · 2015-04-28FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for sotalol hydrochloride by Oxford Pharmaceuticals, LLC. Sotalol is used to treat certain heart…
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: Hybrid AF -- A Prospective Registry
The Hybrid AF prospective registry for atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Current Clinical Practice in the Management of Atrial Fibrillation in Greece: the MANAGE-AF Study
The MANAGE-AF study reports on current clinical practice in the management of atrial fibrillation in Greece and has completed.
-
CLINICAL_TRIALS research · 2015-04-16Clinical Trial Update: Measurement of Left and Right Atria From CT Scans of Cardiac Rhythm Disorder Cases
A clinical trial update describing the measurement of left and right atrial sizes from CT scans in cases of atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Triple vs. Dual Therapy [Phase 1]
The document reports the completion of a Phase 1 trial comparing triple therapy to dual therapy in patients with atrial fibrillation and acu…
-
FDA approval · 2015-04-06FDA Approved: DIGOXIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Digoxin, submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Prediction of Fluid Responsiveness in Atrial Fibrillation Patients Who Underwent Valvular Heart Surgery: Peep-induced Increase in Central Venous Pressure vs. Passive Leg Raising [NA]
A completed clinical trial comparing peep-induced central venous pressure increase versus passive leg raising to predict fluid responsivenes…
-
CLINICAL_TRIALS withdrawal · 2015-03-27Clinical Trial Update: Atrial Fibrillation Ablation The Hybrid Approach Versus Traditional Management [EARLY_Phase 1]
A clinical trial evaluating a hybrid atrial fibrillation ablation approach versus traditional management has been withdrawn from the EARLY P…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation [Phase 3]
Phase 3 trial comparing edoxaban to warfarin in patients with atrial fibrillation has completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting [Phase 3]
A Phase 3 trial evaluating omega-3 fatty acids to prevent atrial fibrillation after coronary artery bypass grafting was terminated.
-
FDA label_change · 2015-03-23FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental labeling application for Cardizem LA (diltiazem hydrochloride extended-release tablets) from Bausch Health US LL…
-
CLINICAL_TRIALS withdrawal · 2015-03-20Clinical Trial Update: A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation [NA]
A prospective multi-centre trial evaluating bipolar radiofrequency ablation for atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: DEtermining Accuracy and TrEnding CharacTerization of AF
A completed Abbott Medical Devices clinical trial evaluating the accuracy and trending characterization of atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Fed-Fasted, Single and Multiple Ascending Dose Trial of XEN-D0103 [Phase 1]
A Phase 1 fed-fasted, single- and multiple-ascending-dose trial of XEN-D0103 by Xention Ltd in atrial fibrillation has completed.